JAMM 2026 Program Book_FINAL

FINAL PROGRAM

February 5-8, 2026 Grand Hyatt Deer Valley Park City, Utah

Dear Colleagues, We are thrilled to welcome you to Park City, Utah, and to the 2026 Joint Arthroplasty Mountain Meeting® (JAMM®) presented in partnership by The Hip Society and The Knee Society.

Whether you have attended previous JAMM® courses, or you decided to try it out for the first time, we are sure you will enjoy your time with us and will leave the course armed with new knowledge, current updates, and valuable connections. What makes JAMM® unique is its robust academic program that is a dynamic blend of didactics, case-based learning, videos, and debates – all presented in a roundtable format to facilitate active participant-faculty interaction. It is our goal to keep the program fresh, fast-paced and stimulating, while allowing ample time for questions and table-side discussions.

A plethora of timely hip and knee arthroplasty topics will be presented by our outstanding faculty of experts, most of whom are members of The Hip Society and The Knee Society. We also encourage you to participate in industry-led sessions to add value to your overall experience.

JAMM® is intentionally informal and fun. You will get the most out of it if you engage in dialogue and discussions with your peers and our faculty. Join us on Thursday evening for a Welcome Reception to meet everyone, to connect, and to embark on a 3-day learning adventure.

Thank you for attending!

1

JAMM® 2026 FACULTY John Antoniou, MD, PhD SMBD - Jewish General Hospital Montreal, QC, Canada

David C. Markel, MD The CORE Institute Novi, MI

Edward M. Vasarhelyi, MD London Health Sciences Centre London, ON, Canada

Michael J. Archibeck, MD University of Utah Salt Lake CIty, UT

David J. Mayman, MD Hospital for Special Surgery New York, NY

Samuel S. Wellman, MD Duke University Durham, NC

Matthew S. Austin, MD Hospital for Special Surgery New York, NY

Richard W. McCalden, MD London Health Sciences Centre London, ON, Canada

Geoffrey H. Westrich, MD Hospital for Special Surgery New York, NY

Henry D. Clarke, MD Mayo Clinic Phoenix, AZ

Douglas D.R. Naudie, MD London Health Sciences Centre London, ON, Canada

P. Maxwell Courtney, MD Rothman Institute Philadelphia, PA

Mark W. Pagnano, MD Mayo Clinic Rochester, MN

Fred D. Cushner, MD Hospital for Special Surgery New York, NY

Wayne G. Paprosky, MD Midwest Orthopaedics at RUSH Westchester, IL

Ronald E. Delanois, MD University of Maryland Baltimore, MD

Christopher E. Pelt, MD University of Utah Salt Lake City, UT

Christopher A. F. Dodd, FRCS Nuffield Health, The Manor Hospital Oxford Oxford, United Kingdom

Christopher L. Peters, MD University of Utah Salt Lake, UT

Elizabeth B. Gausden, MD, MPH Hospital for Special Surgery New York, NY

Ran Schwarzkopf, MD, MSc New York University, NYU Langone Medical Center New York, NY

Jeremy M. Gililland, MD University of Utah Salt Lake City, UT

Roshan P. Shah, MD, JD Columbia University Medical Center New York, NY

George J. Haidukewych, MD Orlando Health Orthopaedic Institute Orlando, FL

Neil P. Sheth, MD University of Pennsylvania Philadelphia, PA

Aaron A. Hofmann, MD Hofmann Arthritis Institute Salt Lake City, UT

James D. Slover, MD, MS Northwell Lenox Hill Hospital New York, NY

James L. Howard, MD, MSc, FRCSC London Health Sciences Centre London, ON, Canada

Eric L. Smith, MD New England Baptist Hospital Boston, MA

Cynthia A. Kahlenberg, MD, MPH Hospital for Special Surgery New York, NY

Mark J. Spangehl, MD Mayo Clinic Scottsdale, AZ

Ormonde M. Mahoney, MD Athens Orthopaedic Clinic Athens, GA

Michael J. Taunton, MD Mayo Clinic Rochester, MN

2

JAMM® 2026 Faculty Disclosure of Relevant Financial Relationships as of 1/12/2026 AAll individuals in a position to influence and/or control the content of AO North America (AO NA) CME activities are required to disclose to AO NA and subsequently to learners that the individual either has no financial relationships or any financial relationships with ineligible companies. An ineligible company is defined as any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Listed below are the disclosures provided by individuals in a position to influence and/or control CME activity content. All of the relevant financial relationships listed for these individuals have been mitigated.

Michael J. Archibeck MD, has disclosed that he receives salary/benefits from Zimmer Biomet Henry D. Clarke, MD, has disclosed that he receives royalties as a consultant for Zimmer Biomet and receives royalties as a consultant for Restor3D/ConforMIS P. Maxwell Courtney, MD, has disclosed that he receives consulting fees as a consultant for Zimmer.

Christopher A. F. Dodd, FRCS, has disclosed that he is a paid consultant, presenter or speaker for and receives IP royalties from Zimmer Biomet.

Elizabeth B. Gausden, MD, MPH, has disclosed she receives consulting fees as a consultant for DePuy. Jeremy M. Gililland, MD, has disclosed that he receives consulting fees/royalties from Enovis, MiCare Path, Stryker and Zimmer Biomet; and he receives equity as an investor in MiCare Path, Sylke, Connextions, OR Innovations and Solenic Medical.

George J. Haidukewych, MD, has disclosed he receives royalties from DePuy Synthes and Zimmer Biomet as an inventor; consulting fees from Smith & Nephew as a consultant; and stock as a consultant for Solenic.

James L. Howard, MD, MSc, FRCSC, has disclosed that he is a paid consultant, presenter or speaker for DePuy, A Johnson & Johnson Company, Intellijoint, Sanofi-Aventis, Smith & Nephew, Stryker and Zimmer; he receives research support from Depuy, A Johnson & Johnson Company; and receives other financial or material support from DePuy, A Johnson & Johnson Company, Microport, Stryker and Zimmer.

Cynthia Kahlenberg, MD, had disclosed that she has professional activities with smith and Nephew Ormonde M. Mahoney, MD, has disclosed that he receives IP royalties and research support and is a paid consultant for Stryker; he is also an unpaid consultant for Surgical Devices, Inc. David J. Mayman, MD, has disclosed he receives consulting fees and royalties as a consultant and inventor from Stryker; he receives royalties as an inventor for Smith & Nephew and Orthoalign; and receives stock options as an inventor for Cymedica, IMagen, MiCare Path, Wishbone, and Ortho AI. Douglas D.R. Naudie, MD, discloses he receives honoraria and royalites as a consultant from Smith & Nephew Mark W. Pagnano, MD, has disclosed he receives IP royalties as a consultant for DePuy/Johnson & Johnson Wayne G. Paprosky, MD, FACS, has disclosed that he receives royalties as a consultant for Zimmer and Medacta and as an author for Springer-Verla; he receives stock as a consultant for Intellijoint.

Christopher E. Pelt, MD, has disclosed that he receives consulting fees, royalties and stock options as a consultant, member of Medical Advisory Board and Speaker's Bureau for Total Joint Orthopedics; he receives research support as Principal Investigator from Zimmer Biomet and Peptilogics; he receives consulting fees as a consultant for Smith & Nephew; he receives stocks as an 3 investor in Joint Development; and receives consulting fees and travel expenses as a consultant for Solventum.

JAMM® 2026 Faculty Disclosure of Relevant Financial Relationships as of 1/12/2026 Ran Schwarzkopf, MD, MSc, has disclosed he receives consulting fees as a consultant for Intellijoint Surgical, Smith & Nephew, and Zimmer Biomet; and he receives equity as a Board member for Parvizi Surgical Innovation.

Roshan P. Shah, MD, has disclosed he has professional activities with Zimmer Biomet Holdings, Inc. James D. Slover, MD, MS, has disclosed he owns stock in Abbott Labs, AbbVie, Bio Rad Labs, Charles River Labs, Con MEd Corp, Conoco Phillips, Eastman Chemical, Hologic, Illumina, Intuitive Surgical, Johnson & Johnson, Kenvue, McKesson, Myriad Genetics, Novartis, Pfizer, Oragenics, Regeneron. Roche, Thermo Fisher, and Vertex.

Eric L. Smith, MD, has disclosed he receives honoraria as a Consultant for DePuy Synthes Michael J. Taunton, MD, has disclosed he receives royalties, consulting fees, and travel expenses for consulting and intellectural property from DJ Ortho Inc. Edward M. Vasarhelyi, MD, has disclosed he receives honorarium for consulting and private investigator for Johnson & Johnson MedTech.

Samuel Wellman, MD, has disclosed he receives consulting fees and travel expenses as a consultant for Total Joint Orthopedics; he receives research support as a Principal Investigator for DePuy Synthes, Medacta, Smith & Nephew, Stryker and Zimmer; and receives speaking fees from serving on the Speaker’s Bureaus for Stryker and Zimmer.

The following faculty and planners have no relevant financial relationships with ineligible companies to disclose: Matthew Austin, MD John Antoniou, MD, PhD Robert L. Barrack, MD Fred D. Cushner, MD Ronald E. Delanois, MD David C. Markel, MD Richard W. McCalden, MD Neil P. Sheth, MD Mark J. Spangehl, MD Geoffrey H. Westrich, MD Cynthia Diaz (Planner) Jola Tricroce (Planner)

4

GENERAL INFORMATION ABOUT THE HIP SOCIETY www.hipsoc.org The Hip Society was established in 1968, by Frank Stinchfield, MD, as a by-invitation only academic society together with twenty elite hip surgeons. The mission of The Hip Society is to advance the knowledge and treatment of hip disorders to improve the lives of our patients.

ABOUT THE KNEE SOCIETY www.kneesociety.org The Knee Society was established in 1983, as a forum for intellectual exchange of concepts in total knee arthroplasty. The main initial goal of the founding group was to bring together the scientific information related to total knee arthroplasty. The mission of The Knee Society is to promote outstanding care to patients with knee disorders through innovative research and education.

REGISTRATION As a pre-registered attendee, you will be receiving a hard copy of the Daily Schedule and a link to the Final Program and handouts. We will not be distributing any printed handouts for this course.

CME ACCREDITATION STATEMENT This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AO North America, Inc.® (AONA) and The Hip Society and The Knee Society. AO North America, Inc.® (AONA) is accredited by the ACCME to provide continuing medical education for physicians.

The AO North America, Inc. designates this live educational activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

If you need to request a copy of the CME Certificate, or have any questions, please email hip@hip-knee.org

COURSE OBJECTIVES The Course Objectives for Joint Arthroplasty Mountain Meeting® (JAMM®) are: Learn techniques of hip and knee revision arthroplasty.

Develop an enhanced understanding of the knee alignment conundrum.

Learn about the increase rise in the number of cementless total knee arthroplasty performed today.

Recognize the compartmental approach to knee arthroplasty.

Learn how distinguished faculty cared for their patients via case presentations.

5

LOCATION All events will take place in Grand Hyatt Deer Park, Jordanelle Ballrooms and Deer Park Ballrooms.

BADGES Valid badges are required for everyone entering the JAMM® designated meeting space, participating in educational events, and partaking of the food and beverage functions. This includes guests of all ages. This policy will be strictly enforced.

SEATING JAMM® experience is built upon a round-table format, with ample time for discussions and interactions. Your badge will have a number corresponding to the table you’ve been assigned to. Please stay at your table for the duration of the course. We will rotate faculty, so you will benefit from different views and teaching styles.

EXHIBITS Please give our exhibitors and sponsors the time and attention they deserve. Visit all exhibitors to learn about their product, services, and the latest technology.

PHOTOGRAPHY Photographs and videos of JAMM® 2026 will be taken throughout the program by authorized staff. By registering for, and attending the events scheduled within the framework of the meeting, participants and their guests agree that their image and name may be used

by The Hip Society and The Knee Society in electronic and print promotional materials and other professional communications including web-based publications, without payment or other consideration.

EVALUATION

CLICK HERE TO SUBMIT YOUR COURSE EVALUATION

If you are active on social media, post photos or videos and use: #JAMM #JAMM2026 #ElevateYourLearning

6

INDUSTRY SPOTLIGHT SESSIONS (NON-CME) THURSDAY, FEBRUARY 5 | 5:10 - 5:55 PM Disease State Education on Desmoid Tumors Presented by

SPEAKERS: Christopher A. F. Dodd, MD

THURSDAY, FEBRUARY 5 | 6:35 - 7:00 PM Oxford Cementless – 50 years of Excellence Presented by

.

SPEAKERS: Fred D. Cushner, MD, George J. Haidukewych, MD, David C. Markel, MD

FRIDAY, FEBRUARY 6 | 8:20 - 8:45 AM The Robotic Knee Revolution + DA360: Personalized Solutions for Hip and Knee Arthroplasty Presented by

Learn how the LEGION MS + CORI Digital Tensioner optimizes knee alignment and how the best in class just got better for hips with the combination of CATALYSTEM and CORIOGRAPH SPEAKERS: George J. Haidukewych, MD, Ran Schwarzkopf, MD

7

INDUSTRY SPOTLIGHT SESSIONS (NON-CME) FRIDAY, FEBRUARY 6 | 5:35 - 6:00 PM A Simplified Hip Revision Experiene with Mako Total Hip Presented by

Join to experience the next evolution in robotic-assisted hip revision surgery using the Mako Total Hip Advance Primary and Revision software through the Direct Anterior Approach.

SPEAKER: Elizabeth B. Gausden, MD, David J. Mayman, MD

SATURDAY, FEBRUARY 7 | 8:05 - 8:30 AM Advances and Insights in Surgical Wound Closure Presented by

MODERATOR: Roshan P. Shah, MD, JD PANEL: Eizabeth B. Gausden, MD, Jeremy M. Gililland,MD, David J. Mayman, MD, Ormonde M. Mahoney, MD, Mark J. Spangehl, MD, Ran Schwarzkopf, MD

8

Network: JAMM2026 Password: HipKnee!

DAILY SCHEDULE JAMM 2026 | February 5-8 Grand Hyatt Deer Valley, Park City, UT

THURSDAY - FEBRUARY 5, 2026 1:00-5:00pm 4:30-4:35pm

ATTENDEE CHECK-IN

Jordanelle Ballroom Foyer

DAY 1: WELCOME | INTRODUCTIONS | ANNOUCEMENTS

SESSION I 4:35-4:50pm

DEBATE: SHOULD ADVANCED TECHNOLOGY BE USED IN ALL THAs?

4:35-4:40pm 4:40-4:45pm 4:45-4:50pm

Pro Con Discussion

SESSION II 4:50-5:05pm

PUSHING THE ENVELOPE FOR OUTPATIENT THA

4:50-4:55pm 4:55-5:00pm 5:00-5:05pm

Most of My Hips Are Outpatient I Still Keep Patients Overnight Discussion

5:10-5:55pm

7:00-8:00pm

Jordanelle Ballroom Moderator: Neil P. Sheth, MD Matthew S. Austin, MD James D. Slover, MD

NON-CME INDUSTRY SPOTLIGHT PRESENTED BY: SpringWorks Therapeutics

Deer Creek Ballroom A Dipak Ramkumar, MD

CHALLENGING CASES WITH MODERATORS

Jordanelle Ballroom Moderators: Henry D. Clarke, MD, George J. Haidukewych, MD

Hip Cases Knee Cases 6:35-7:00pm

Jordanelle Ballroom Moderator: Richard W. McCalden, MD Jeremy M. Gililland, MD Christopher L. Peters, MD

Disease State Education on Desmoid Tumors SESSION III 6:00- 6:30pm

Jordanelle Ballroom Fred D. Cushner, MD

NON-CME INDUSTRY SPOTLIGHT PRESENTED BY: Zimmer Biomet

Deer Creek Ballroom A

Oxford Cementless – 50 years of Excellence

Christopher A. F. Dodd, FRCS

WELCOME RECEPTION WITH EXHIBITORS

Jordanelle Ballroom A-B

FRIDAY - FEBRUARY 6, 2026 6:00-6:45am 6:45am

BREAKFAST WITH EXHIBITORS DAY 2: WELCOME | ANNOUCEMENTS

SESSION IV 6:45 – 7:00am

DEBATE: FIXATION IN TKA

6:45-6:50am 6:50-6:55am 6:55-7:00am

Cemented is the Standard Cementless for Most Discussion

Jordanelle Ballroom A-B Jordanelle Ballroom Christopher L. Peters, MD Jordanelle Ballroom Moderator: Christopher L. Peters, MD Mark J. Spangehl, MD Geoffrey H. Westrich, MD

9

SESSION V 7:00-7:30am

CASE PRESENTATIONS

7:00-7:10am 7:10-7:20am 7:20-7:30am

PFJ Case Medial and Patella DJD? Bicompartmental Painful UKA- When and How to Revise

SESSION VI 7:30-8:15am

DEBATES

7:30-7:35am 7:35-7:40am 7:40-7:45am

UKA UKA is Underutilized UKA Not Often Needed Discussion

7:45-7:50am 7:50-7:55am 7:55-8:00am

ROBOTS AND UKA Robots Not Required for Good Results UKA Should be Done With a Robot Discussion

8:00-8:05am 8:05 -8:10am 8:10-8:15am

PF DJD AND UKA – HOW MUCH IS TOO MUCH? You Can (Mostly) Ignore the Patella TKA if Patella DJD Present Discussion

8:20-8:45am

NON-CME INDUSTRY SPOTLIGHT PRESENTED BY: Smith+Nephew The Robotic Knee Revolution + DA360: Edcuation to Outcomes: Personalized Solutions for Hip and Knee Arthroplasty

SESSION VII 8:50-9:55am

UNCEMENTED TKA

8:50-9:00am 9:00-9:10am 9:10-9:20am 9:20-9:30am 9:30-9:40am 9:40-9:55am

Criteria for Uncemented TKA Uncemented TKA and the Obese Patient Uncemented Patella is the Key Uncemented UKA Infection and the UKA Discussion

9:55-10:25am

MORNING BREAK WITH EXHIBITORS

SESSION VIII 10:25-11:30am

PERIPROSTHETIC HIP FRACTURE

10:25-10:30am 10:30-10:35am 10:35-10:40am 10:40-10:45am 10:45-10:52am 10:52-10:59am 10:59-11:06am 11:06-11:13am 11:13-11:20am 11:20-11:30am

DEBATE: STEM CHOICE MAKES A DIFFERENCE IN FRACTURE RATE The Triple Taper Reduces Periprosthetic Fracture Risk There is Still a Role for Blade Stems Cement in Certain Situations Makes the Most Sense Discussion DIDACTIC TALKS How to Manage the Intraoperative Calcar Fracture During DAA How to Manage the Early B2 Fracture How to Manage Vancouver C and Other Complex Periprosthetic Fractures DA Revision Tips and Tricks for Fracture and Other Revisions Posterior Approach Tips and Tricks for Fracture and Other Revisions Discussion

Jordanelle Ballroom Moderator: Christopher L. Peters, MD Christopher E. Pelt, MD David J. Mayman, MD Cynthia Kahlenberg, MD Jordanelle Ballroom Moderator: Fred D. Cushner, MD Christopher A. F. Dodd, FRCS Wayne G. Paprosky, MD

Christopher A. F. Dodd, FRCS Mark W. Pagnano, MD

Cynthia Kahlenberg, MD Douglas D.R. Naudie, MD

Deer Creek Ballroom A George J. Haidukewych, MD Ran Schwarzkopf, MD Jordanelle Ballroom Moderator: Geoffrey H. Westrich, MD David C. Markel, MD Ronald E. Delanois, MD Fred D. Cushner, MD Christopher A. F. Dodd, FRCS Henry D. Clarke, MD

Jordanelle Ballroom A-B Jordanelle Ballroom Moderator: Matthew S. Austin, MD Michael J. Archibeck, MD P. Maxwell Courtney, MD Richard W. McCalden, MD

Christopher E. Pelt, MD John Antoniou, MD George J. Haidukewych, MD Jeremy M. Gililland, MD Samuel S. Wellman, MD

10

11:30-4:00pm

AFTERNOON BREAK | PLEASE RETURN ON TIME

4:00-4:30pm

APRÈS SKI | REFRESHMENTS WITH EXHIBITORS

SESSION IX 4:30-5:30pm

HIP CASES AND TABLE DISCUSSIONS

4:30-4:40pm 4:40-4:50pm 4:50-5:00pm 5:00-5:10pm 4:30-5:35pm 5:20-5:30pm

THA in Patient S/P ORIF Acetabular FX THA in Crowe III–IV DDH THA in Patient with Failed Femoral ORIF THA in Patient with Femoral Deformity THA in Little People Video-Based: THA in 85-Year-Old Osteopenic Female – How to Cement a Femoral Stem

5:35-6:00pm

NON-CME INDUSTRY SPOTLIGHT PRESENTED BY: Stryker A Simplified Hip Revision Experience with Mako Total Hip

SESSION X 6:05-7:15pm

COMPLEX PRIMARY KNEES – CASES AND TABLE DISCUSSIONS

6:05-6:15pm 6:15-6:25pm 6:25-6:35pm 6:35-6:45pm 6:45-6:55pm 6:55-7:05pm 7:05-7:15pm

BMI 50 Retained Hardware Stiff Knee Video-Based: Severe Valgus Video-Based: Severe Varus Extraarticular Deformity Operation Walk: Getting More By Giving Back

Jordanelle Ballroom A-B Jordanelle Ballroom Moderator: John Antoniou, MD Elizabeth B. Gausden, MD James L. Howard, MD George J. Haidukewych, MD John Antoniou, MD Wayne G. Paprosky, MD Richard W. McCalden, MD

Deer Creek Ballroom A Elizabeth B. Gausden, MD David J. Mayman, MD Jordanelle Ballroom Moderator: Fred D. Cushner, MD Fred D. Cushner, MD Ormonde M. Mahoney, MD James D. Slover, MD Henry D. Clarke, MD Eric L. Smith, MD David C. Markel, MD Matthew S. Austin, MD

SATURDAY - FEBRUARY 7, 2026 6:00-6:45am 6:45am

BREAKFAST WITH EXHIBITORS DAY 3: WELCOME | ANNOUCEMENTS

SESSION XI 6:45 – 7:00am

BEARING SURFACES IN TKA

6:45-6:50am 6:50-6:55am 6:55-7:00am

MC Bearing is Here and PS is Obsolete PS Bearing Remains More Appropriate When PCL is Sacrificed Discussion

SESSION XII 7:00-8:00am

CONTEMPORARY ISSUES IN PERIOPERATIVE CARE

7:00-7:07am 7:07-7:14am

30 Year Experience with Cementless TKA Wound Care Advancements in TJA and Prevention of Wound Healing Issues With DAA Patient Engagement Platforms Can Enhance Your Practice Wound Closure 2026: What We Have Learned Outpatient TJA Experience in a Tertiary Hospital Environment What Did We Learn from the Latest International Consensus Meeting on Infection?

Perioperative Care: What Does the Evidence Say about BMI, Smoking, Diabetes and Other Modifiable Risk Factors Discussion

7:14-7:21am 7:21-7:28am 7:28-7:35am 7:35-7:42am 7:42-7:49am 7:49-8:00am

Jordanelle Ballroom A-B Jordanelle Ballroom Christopher L. Peters, MD Jordanelle Ballroom Moderator: Matthew S. Austin, MD James L. Howard, MD Cynthia Kahlenberg, MD

Jordanelle Ballroom Moderator: Ronald E. Delanois, MD Aaron A. Hofmann, MD Roshan P. Shah, MD Christopher L. Peters, MD David J. Mayman, MD Christopher E. Pelt, MD Mark J. Spangehl, MD Edward M. Vasarhelyi, MD

11

8:05-8:30am

NON-CME INDUSTRY SPOTLIGHT PRESENTED BY:

Sylke

Deer Creek Ballroom A

Advances and Insights in Surgical Wound Closure

Moderator: Roshan P. Shah, MD, JD Panel: Elizabeth B. Gausden, MD,Jeremy M. Gililland,MD, David J. Mayman, MD Ormonde M. Mahoney, MD, Mark J. Spangehl, MD, Ran Schwarzkopf, MD

SESSION XIII 8:35-9:30am

PRIMARY TKA

8:35-8:40am 8:40-8:45am 8:45-8:50am 8:50-8:55am 8:55-9:00am 9:00-9:05am 9:05-9:10am 9:10-9:15am 9:15-9:30am

Personalized Alignment Has Revolutionized TKA I prefer Image Based Robotics No Image Needed for My Robot I Still Like My Tourniquet Time to Change- No Tourniquet Needed Wound Closure/Wound Management 2026 Perioperative Medication Update: What I Use and Why GLP-1's and the Arthroplasty Patient Update on Dental Prophylaxis- What is Really Needed

9:30-10:30am

MORNING BREAK WITH EXHIBITORS

SESSION XIV 10:00-11:30am

PRIMARY THA

10:00-10:08am 10:08-10:16am 10:16-10:24am 10:24-10:32am 10:32-10:40am 10:40-10:48am 10:48-10:56am 10:56-11:04am 11:04-11:12am 11:12-11:20am 11:20-11:30am

Direct Anterior THA with Fluoro Guidance Anterior Based Muscle Sparing Approach with Low Tech Posterior Approach with Robotic Assistance The French Paradox Concept for Cemented Stems Wagner Cone for Challenging Primaries The Cementless Collared Tri-Taper Stem is the Only Way to Go! AR/VR Technology for Primary THA Acetabular Cup Primer – From Routine to Complex Ceramic on Highly Cross-Linked Polyethylene is the Only Couple to Consider Dual-Mobility Bearings Make Sense for Most Primaries Discussion

11:30-4:00pm

AFTERNOON BREAK | PLEASE RETURN ON TIME

4:00-4:30pm

APRÈS SKI | REFRESHMENTS WITH EXHIBITORS

SESSION XV 4:30-5:40pm

REVISION THA: CASE PRESENTATIONS AND TABLE DISCUSSIONS

4:30-4:40pm 4:40-4:50pm 4:50-5:00pm 5:00-5:10pm 5:10-5:20pm 5:20-5:30pm 5:30-5:40pm

Revising the Loose Cementless Femoral Component Revising the Loose Cemented Femoral Component Revising the Recurrent Dislocator Revising for Taper Corrosion Revising for Pelvic Discontinuity ORIF vs. Revising for Periprosthetic Femoral Fracture How I Do an Antibiotic Loaded Spacer for Infected THA

Jordanelle Ballroom Moderator: Mark W. Pagnano, MD Henry D. Clarke, MD David J. Mayman, MD Christopher L. Peters, MD Matthew S. Austin, MD Ronald E. Delanois, MD Elizabeth B. Gausden, MD Neil P. Sheth, MD Mark J. Spangehl, MD Ormonde M. Mahoney, MD

Jordanelle Ballroom A-B Jordanelle Ballroom Moderator: James D. Slover, MD Jeremy M. Gililland, MD Ronald E. Delanois, MD David J. Mayman, MD Ran Schwarzkopf, MD James L. Howard, MD Mark W. Pagnano, MD Michael J. Taunton, MD Douglas D.R. Naudie, MD Ran Schwarzkopf, MD Neil P. Sheth, MD

Jordanelle Ballroom A-B Jordanelle Ballroom Moderator: David J. Mayman, MD Michael J. Taunton, MD John Antoniou, MD Edward M. Vasarhelyi, MD Douglas D.R. Naudie, MD Neil P. Sheth, MD David C. Markel, MD Ran Schwarzkopf, MD

12

SESSION XVI 5:40-6:40pm

REVISION TKA: CASE PRESENTATIONS AND TABLE DISCUSSIONS

5:40-5:50pm 5:50-6:00pm 6:00-6:10pm 6:10-6:20pm 6:20-6:30pm 6:30-6:40pm

Conversion of a Failed Uni ORIF or Revision for Periprosthetic Fracture Revision for Instability Revision for Aseptic Loosing with Collapse and Bone Loss Revision for Stiffness Looks Good but Feels Bad

Jordanelle Ballroom Moderator: Christopher A. F. Dodd, FRCS Christopher A. F. Dodd, FRCS Elizabeth B. Gausden, MD Matthew S. Austin, MD Geoffrey H. Westrich, MD Samuel Wellman, MD Eric L. Smith, MD

SUNDAY - FEBRUARY 8, 2026 6:00-6:45am 6:45am

BREAKFAST WITH EXHIBITORS

Jordanelle Ballroom A-B

DAY 4: WELCOME | ANNOUCEMENTS

Jordanelle Ballroom Christopher L. Peters, MD

SESSION XVII 6:45 – 7:05am

DEBATE: THE INFECTED THA – ONE STAGE VS. TWO STAGE VS. 1.5 STAGE

6:45-6:50am 6:50-6:55am 6:55-7:00am 7:00-7:05am

One Stage Two Stage 1.5 Stage Discussion

SESSION XVIII 7:05-8:00am

REVISION TKA

7:05-7:13am 7:13-7:23am 7:23-7:31am 7:31-7:39am 7:39-7:47am 7:47-7:55am 7:55-8:00am

Tips on Exposure for Revision Video-Based: How to Remove the Prosthesis and Save Bone I Prefer Cones with Cemented Stems I Prefer Cones with Cementless Stem Fixation How to Do the Revision with Cemented Stems in Place How Much Constraint Do I Need?

Discussion

SESSION XIX 8:00-9:00am

REVISION HIP

8:00-8:08am 8:08-8:16am 8:16-8:24am 8:24-8:32am 8:32-8:40am 8:40-8:48am 8:48-9:00am

Tips for Successful Extended Trochanteric Osteotomy Tips for Successful Wagner Osteotomy Acetabular Revision: Ultra-Porous Cups, Augments, Cages Custom Tri-flange Makes Revision Easier I Prefer Modular Monoblock Titanium Tapered Splined Stems I Prefer Modular Titanium Tapered Splined Stems Discussion

9:00-9:30am

MORNING BREAK WITH EXHIBITORS

SESSION XX 9:30-10:30am

COMPLEX CASE PRESENTATIONS

9:30-9:40am 9:40-9:50am 9:50-10:00am 10:10-10:10am 10:10-10:20am 10:20-10:30am

Complex Case Complex Case Complex Case Complex Case Complex Case Closing Remarks / Final Questions for Faculty

10:30am

ADJOURN

Jordanelle Ballroom

Moderator: Christopher E. Pelt, MD Eric L. Smith, MD Samuel Wellman, MD Jeremy M. Gililland, MD

Jordanelle Ballroom Moderator: Ormonde M. Mahoney, MD Matthew S. Austin, MD Geoffrey H. Westrich, MD Ran Schwarzkopf, MD P. Maxwell Courtney, MD Roshan P. Shah, MD, JD Ormonde M. Mahoney, MD

Jordanelle Ballroom Moderator: P. Maxwell Courtney, MD Wayne G. Paprosky, MD Michael J. Taunton, MD P. Maxwell Courtney, MD James D. Slover, MD Richard W. McCalden, MD Michael J. Archibeck, MD

Jordanelle Ballroom A-B Jordanelle Ballroom Moderator: Michael J. Archibeck, MD Roshan P. Shah, MD, JD Edward M. Vasarhelyi, MD Cynthia Kahlenberg, MD Mark Spangehl, MD Fred D. Cushner, MD

13

THE HIP SOCIETY AND THE KNEE SOCIETY THANK THE FOLLOWING COMPANIES FOR THEIR SUPPORT OF JAMM® 2026 THROUGH SPONSORSHIPS AND EXHIBITS We encourage all participants and faculty to visit and interact with our exhibitors during designated unopposed exhibit times.

INDUSTRY PARTNERS

14

EXHIBITORS

Arthro-Positioning Systems - Exhibit Space 6 www.arthropositioningsystems.com Arthro-Positioning Systems is devoted to making positioning the body for surgery as simple, intuitive, and effective as possible. Our device, the Velocity Bump, eliminates the need for costly and time-consuming sterile processing and allows clinicians to put the joint Where they want it, When they want it.

Bone Support – Exhibit Space 8 www.bonesupport.com/en-us/ BONESUPPORT is advancing bone infection management for Arthroplasty, Trauma and Foot & Ankle surgeons. We are an orthobiologics company and the maker CERAMENT® G with Gentamicin, the only FDA authorized bone remodeling technology that is injectable and elutes antibiotics. Our products are effective in treating patients with fractures and bone voids caused by trauma, infection, disease or related surgery.

Decipthera – Exhibit Space 7 www.deciphera.com We are a commercial-stage biopharmaceutical company on a mission to deliver transformational medicines to patients. Headquartered in Waltham, MA with research facilities in Lawrence, KS, we develop innovative science to provide hope to people living with cancer.”

DePuy Synthes – Exhibit Space 14 www.jnjmedtech.com/en-US/companies/depuy-synthes DePuy Synthes provides one of the most comprehensive orthopaedics portfolios in the world that helps heal and restore movement for the millions of patients we serve. DePuy Synthes solutions, in specialties including joint reconstruction, trauma, extremities, craniomaxillofacial, spinal surgery and sports medicine, in addition to the VELYS™ Enabling Tech portfolio, are designed to advance patient care while delivering clinical and economic value.

15

EXHIBITORS

Innomed - Exhibit Space 6 www.innomed.net Innomed, Inc., a developer of instruments for orthopedic surgery, continues to introduce new and innovative products. We offer an array of unique instruments and patient positioning devices, designed by or in conjunction with orthopedic surgeons and surgical professionals.

Medacta – Exhibit Space 9 www.medacta.us.com Medacta is specialized in the design, production, and distribution of innovative orthopedic products and surgical techniques, supporting surgeons with comprehensive and tailored programs of medical education. Medacta is committed to improving the care and well-being of patients focusing on healthcare sustainability. Medacta’s innovation, forged by close collaboration with expert surgeons, began with minimally invasive techniques and has evolved into personalized solutions for every patient.

OrthAlign, Inc. – Exhibit Space 12 www.orthalign.com OrthAlign is driven by the belief that everyone deserves exceptional health care. Our technology provides surgeons with live navigation in knee & hip replacements in any OR with any implant

Smith+Nephew – Exhibit Spaces 10-11 www.jnjmedtech.com/en-US/companies/depuy-synthes Smith+Nephew is a global medical technology business with global leadership positions in Orthopaedic Reconstruction, Sports Medicine, Trauma Fixation, Extremities & Limb Restoration, and Advanced Wound Management. Visit www.smith-nephew.com for more information.

16

EXHIBITORS

SpringWorks – Exhibit Space 5 www.springworkstx.com

Sylke – Exhibit Space 13 www.sylke.com SYLKE® was launched in December 2023 to provide a safer solution to the complications caused by synthetic wound dressings. Made from 99.9999% silk fibroin—a natural, nonimmunogenic protein renowned for its strength, flexibility, and biocompatibility—SYLKE® serves as both a closure device and dressing. It protects wounds, manages exudate, and mimics skin elasticity to improve comfort and patient outcomes, making it an ideal choice for surgical incisions, emergency lacerations, and at-home care.

TJO Inc.– Exhibit Space 4 www.tjoinc.com TJO is committed to bringing innovation to orthopedics. TJO is surgeon-founded and surgeon-focused, and every implant and instrument is designed with the user in mind. A combination of intelligent engineering and direct user feedback has led to an intuitive, consistent experience resulting in exceptional patient outcomes. Please stop by our table to learn how TJO can improve your workflow and the surgical experience for patients and staff.

Zimmer Biomet – Exhibit Spaces 2-3 www.ZimmerBiomet.com Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.

17

SAVE THE DATES!

DECEMBER 9-12, 2026 ORLANDO, FLORIDA

CCJR® 2026: YOUR FRONT ROW SEAT TO WHAT’S NEXT! www.CCJR.com

18

The Hip Society | The Knee Society 155 East Woodfield Road, Suite 345 Schaumburg, IL 60173 hip@hip-knee.org | knee@hip-knee.org

19